NEW YORK (AP) — Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin. The study compared renal cell carcinoma ...

(Reuters) - Pfizer Inc said on Friday that a late-stage trial of its drug for renal cell cancer failed to meet its main goal when given in combination with Avastin, a drug made by Roche Holding AG.

Pfizer Inc. PFE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending marketing authorization for ...

> The Seraing, Belgium, manufacturing facility of contract manufacturer Eurogentec has completed an FDA preapproval inspection and been given acceptable status, thus allowing it to make a bulk ...

(Reuters) - A panel of European Medicines Agency (EMA) on Friday recommended approval for Pfizer Inc's Zirabev, a cheaper version to Roche Holding AG's leading cancer drug Avastin. Pfizer's Zirabev is ...

(Reuters) - Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin. Pfizer's Zirabev received ...

US pharmaceutical giant Amgen has become the first company to seek regulatory approval to sell an Avastin biosimilar in Europe, taking the lead in the race to introduce cheaper replicas of the ...

Pfizer Inc., Genentech Inc. and ImClone Systems Inc. will receive broader Medicare reimbursements for use of their colon cancer drugs in clinical trials, the federal government announced Monday.